2 completed, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Terminated 1 |
Follow interferon alfacon-1: new trials by email Literature Review of interferon alfacon-1 trials Research Report on interferon alfacon-1
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Infergen and Ribavirin Treatment of Patients With HCV Who Achieved Partial Response to Peginterferon-alfa and Ribavirin Infergen and ribavirin - Hepatitis C | Phase 4 | Terminated | Kadmon Corporation, LLC | 5 | 2007-02-01 | 2012-10-15 |
| Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy Interferon Alfacon-1 and Ribavirin - Hepatitis C | Phase 4 | Completed | Beth Israel Medical Center | 40 | 2005-12-01 | 2008-04-17 |
| Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin rosiglitazone - Hepatitis C | Phase 4 | Completed | Brooke Army Medical Center | 34 | 2005-10-01 | 2012-02-14 |
Hepatitis C (3) · Hepatitis C, Chronic (1) · Insulin Resistance (1)
Beth Israel Medical Center (1) · Brooke Army Medical Center (1) · Kadmon Corporation, LLC (1)
United States (3)
Henry C. Bodenheimer, M.D. (1) · Mitchell L Schiffman, MD (1) · Shane Mills, MD (1) · Stephen A Harrison, MD (1)